A detailed history of Amalgamated Bank transactions in Biote Corp. stock. As of the latest transaction made, Amalgamated Bank holds 472 shares of BTMD stock, worth $2,459. This represents 0.0% of its overall portfolio holdings.

Number of Shares
472
Previous 472 -0.0%
Holding current value
$2,459
Previous $4,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$3.79 - $6.91 $4,169 - $7,601
-1,100 Reduced 69.97%
472 $3,000
Q4 2023

Feb 06, 2024

SELL
$4.43 - $5.81 $620 - $813
-140 Reduced 8.18%
1,572 $8,000
Q2 2023

Aug 11, 2023

BUY
$5.27 - $6.9 $9,022 - $11,812
1,712 New
1,712 $11,000

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $39.5M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.